线粒体单倍群修饰2型糖尿病患者糖尿病病程与HbA1c对增殖性糖尿病视网膜病变风险的影响
本研究纳入2型糖尿病伴糖尿病视网膜病变(DR)患者377例和不伴DR患者480例,比较欧洲线粒体单倍群间糖尿病病程和HbA1c的差异,并用逻辑回归分析各单倍群下二者与增殖性糖尿病视网膜病变(PDR)风险的关联。结果发现单倍群H的DR患者中,较长糖尿病病程和较高HbA1c是PDR的显著危险因素(P=0.0001和P=0.011),而单倍群UK的DR患者中二者均不是显著危险因素。结论认为欧洲线粒体单倍群可修饰糖尿病病程和HbA1c对PDR风险的影响,或可部分解释病程和血糖控制相似的患者中PDR发生与否的差异。
要点
- 单倍群H的DR患者中,较长糖尿病病程和较高HbA1c是PDR的显著危险因素。
- 单倍群UK的DR患者中,糖尿病病程和HbA1c均不是PDR的显著危险因素。
- 欧洲线粒体单倍群可修饰糖尿病病程和HbA1c对PDR风险的影响。
核心结论
- 欧洲线粒体单倍群可修饰2型糖尿病患者糖尿病病程和HbA1c对PDR风险的影响。
- 在本研究人群中,单倍群H患者较长糖尿病病程和较高HbA1c增加PDR风险,而单倍群UK患者中二者不影响PDR风险。
- 作者认为该关系此前未被证实,或可部分解释非增殖性DR患者中PDR发生与否的差异。
研究设计与样本
- 研究人群为2型糖尿病伴DR患者377例和不伴DR患者480例。
- 采用Kruskal-Wallis检验比较各线粒体单倍群间糖尿病病程和HbA1c。
- 采用逻辑回归分析各欧洲线粒体单倍群背景下糖尿病病程和HbA1c作为PDR危险因素的作用。
主要发现
- 各线粒体单倍群间糖尿病病程和HbA1c均无差异。
- 单倍群H的DR患者中,较长糖尿病病程是PDR的显著危险因素(P=0.0001)。
- 单倍群H的DR患者中,HbA1c升高是PDR的显著危险因素(P=0.011)。
- 单倍群UK的DR患者中,糖尿病病程和HbA1c均不是PDR的显著危险因素。
关键数值与推荐
- 单倍群H的DR患者中,糖尿病病程与PDR风险的逻辑回归P=0.0001。
- 单倍群H的DR患者中,HbA1c与PDR风险的逻辑回归P=0.011。
- 单倍群UK的DR患者中,糖尿病病程和HbA1c均不是PDR的显著危险因素(原文未报告具体P值)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We previously demonstrated an association between European mitochondrial haplogroups and proliferative diabetic retinopathy (PDR). The purpose of this study was to determine how the relationship between these haplogroups and both diabetes duration and hyperglycemia, two major risk factors for diabetic retinopathy (DR), affect PDR prevalence. METHODS: Our population consisted of patients with type 2 diabetes with (n = 377) and without (n = 480) DR. A Kruskal-Wallis test was used to compare diabetes duration and hemoglobin A1c (HbA1c) among mitochondrial haplogroups. Logistic regressions were performed to investigate diabetes duration and HbA1c as risk factors for PDR in the context of European mitochondrial haplogroups. RESULTS: Neither diabetes duration nor HbA1c differed among mitochondrial haplogroups. Among DR patients from haplogroup H, longer diabetes duration and increasing HbA1c were significant risk factors for PDR (P = 0.0001 and P = 0.011, respectively). Neither diabetes duration nor HbA1c was a significant risk factor for PDR in DR patients from haplogroup UK. CONCLUSIONS: European mitochondrial haplogroups modify the effects of diabetes duration and HbA1c on PDR risk in patients with type 2 diabetes. In our patient population, longer diabetes duration and higher HbA1c increased PDR risk in patients from haplogroup H, but did not affect PDR risk in patients from haplogroup UK. This relationship has not been previously demonstrated and may explain, in part, why some patients with nonproliferative DR develop PDR and others do not, despite similar diabetes duration and glycemic control.
引用
- Mitchell SL, Neininger AC, Bruce CN, et al. Mitochondrial Haplogroups Modify the Effect of Diabetes Duration and HbA1c on Proliferative Diabetic Retinopathy Risk in Patients With Type 2 Diabetes. Invest Ophthalmol Vis Sci. 2017. PMID: 29288266. doi:10.1167/iovs.17-22804
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。